Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
| ||||
| ||||
| Three months ended | Twelve months ended | ||
| December 31, | December 31, | ||
| 2023 | 2022 | 2023 | 2022 |
| Unaudited | Unaudited | Unaudited | Unaudited |
GAAP net income (loss) | $ 3,769 | $ 1,940 | $ (11,878) | $ (23,183) |
Equity-based compensation expense included in cost of revenues | 190 | 176 | 826 | 687 |
Equity-based compensation expense included in research and
| 2,430 | 2,271 | 9,133 | 8,259 |
Equity-based compensation expense included in sales and
| 471 | 473 | 1,776 | 1,503 |
Equity-based compensation expense included in general and
| 1,008 | 884 | 3,795 | 2,888 |
Amortization, Impairment and Write-off of intangible assets | 278 | 370 | 1,031 | 8,163 |
Costs associated with business acquisitions | 356 | - | 551 | - |
(Income) loss associated with the remeasurement of marketable
| (74) | 240 | 2 | 2,511 |
Impairment cost associated with close of an office | - | 318 | - | 318 |
Retirement expenses of executives | - | 1,271 | - | 1,271 |
Income tax expense as a result of a write off of a deferred tax asset
|
- |
- |
- |
15,323 |
Income tax expenses, an impact as a result of the completion of a
|
1,302 |
- |
1,302 |
- |
Adjustment related to US tax reform rule 174 | 4,460 | (3,484) | 4,460 | (3,484) |
Non-GAAP from discontinued operation | (11,812) | 1,143 | (8,579) | 4,579 |
Non-GAAP net income | $2,378 | $ 5,602 | $ 2,419 | $ 18,835 |
GAAP weighted-average number of Common Stock used in
| 23,518 | 23,406 | 23,484 | 23,172 |
Weighted-average number of shares related to outstanding stock-
| 1,271 | 684 | 1,197 | 839 |
Weighted-average number of Common Stock used in computation
| 24,789 | 24,090 | 24,681 | 24,011 |
|
|
|
|
|
GAAP diluted income (loss) per share | $ 0.16 | $ 0.08 | $ (0.51) | $ (1.00) |
Equity-based compensation expense | $ 0.17 | $ 0.16 | $ 0.66 | $ 0.57 |
Amortization, Impairment and Write-off of intangible assets | $ 0.01 | $ 0.02 | $ 0.04 | $ 0.35 |
Impairment cost associated with close of an office | - | $ 0.01 | - | $ 0.01 |
Costs associated with business acquisitions | $ 0.02 | - | $ 0.02 | - |
Income associated with the remeasurement of marketable equity
| - | $ 0.01 | - | $ 0.09 |
Retirement of executives
| - | $ 0.05 | - | $ 0.05 |
Adjustment related to income tax expenses | $ 0.24 | ($ 0.15) | $ 0.25 | $ 0.51 |
Non-GAAP from discontinued operation | ($ 0.50) | $ 0.05 | ($ 0.36) | $ 0.20 |
Non-GAAP diluted earnings per share | $ 0.10 | $ 0.23 | $ 0.10 | $ 0.78 |
| ||||
| ||||
| Three months ended | Twelve months ended | ||
| December 31, | December 31, | ||
| 2023 | 2022 | 2023 | 2022 |
| Unaudited | Unaudited | Unaudited | Unaudited |
GAAP Operating Income (loss) | $ (2,787) | $ 1,009 | $ (13,467) | $ 3,896 |
Equity-based compensation expense included in cost of
| 190 | 176 | 826 | 687 |
Equity-based compensation expense included in
| 2,430 | 2,271 | 9,133 | 8,259 |
Equity-based compensation expense included in sales
| 471 | 473 | 1,776 | 1,503 |
Equity-based compensation expense included in
| 1,008 | 884 | 3,795 | 2,888 |
Amortization, Impairment and Write-off of intangible
| 278 | 370 | 1,031 | 8,163 |
Costs associated with the Business acquisition | 356 | - | 551 | - |
Retirement of executives | - | 1,271 | - | 1,271 |
Impairment cost associated with close of an office | - | 318 | - | 318 |
Total non-GAAP Operating Income | $ 1,946 | $ 6,772 | $ 3,645 | $ 26,985 |
| ||||
| ||||
| Three months ended | Twelve months ended | ||
| December 31, | December 31, | ||
| 2023 | 2022 | 2023 | 2022 |
| Unaudited | Unaudited | Unaudited | Unaudited |
|
|
|
|
|
GAAP Gross Profit | $ 21,903 | $ 27,056 | $ 85,771 | $ 105,452 |
GAAP Gross Margin | 91 % | 89 % | 88 % | 87 % |
|
|
|
|
|
Equity-based compensation expense included in cost of
| 190 | 176 | 826 | 687 |
Amortization, Impairment and Write-off of intangible
| 129 | 71 | 437 | 2,582 |
Total Non-GAAP Gross profit | 22,222 | 27,303 | 87,034 | 108,721 |
Non-GAAP Gross Margin | 92 % | 90 % | 89 % | 90 % |